webmaster, Author at LGC

Infectious disease researchers publish routes to ensure lessons are learned from COVD-19 when using PCR for monkeypox diagnosis

16 August 2022

The paper, titled “Monkeypox: another test for PCR”, focuses on how to ensure the PCR diagnosis tests being deployed for monkeypox will be most accurate and that lessons learned on PCR testing from the COVID-19 pandemic are applied to the current epidemic.

LGC Clinical Diagnostics extend collaboration with Stanford Medicine supporting global genetic and metabolomic diagnostic testing

02 August 2022

The exclusive partnership will also be extended to include the analysis of phenotypic-genotypic correlations and metabolic profiling of some common maternal/ fetal cardiac defects known to be related to monogenic disorders.

LGC launches free app-based cannabis testing training to support cannabis testing laboratories in their learning

01 July 2022

Easy-to-use app-based microlearning provides training in a range of cannabis-related topics

LGC to distribute InBio’s food allergen reference materials and immunoassays

23 June 2022

Expands LGC’s offering to more than 180 allergen reference materials for a range of applications including method development and method verification

LGC Board Change

13 June 2022

Update

LGBTQ scientists throughout history and the future

09 June 2022

As we continue to celebrate Pride month, let’s take a look at several famous LGBTQ scientists throughout history that have changed and continue to change the world.

National agrifood partnership launched at Queen’s University Belfast

26 May 2022

We're pleased to launch the Centre for Excellence in Agriculture and Food Integrity, a strategic partnership to enhance and future-proof the UK agrifood industry through the development and application of innovative scientific-measurement solutions and digital technologies for greater assurance of the sustainability, reliability, safety and productivity of inherent supply chains.

Ampersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder

17 May 2022

DDS is a European provider of Bioanalytical and Analytical and Materials Science Solutions to pharma, biopharma, consumer healthcare and consumer products clients, located in Cambridge and Sandwich, UK

Enabling the recycling of technology critical elements from e-waste

11 May 2022

our Inorganic Analysis team at the UK National Measurement Laboratory at LGC are working with partners across Europe and the recycling industry to develop and underpin analytical methods to determine the presence of technology critical elements, within electronic waste samples. This knowledge can then be used by the industry to determine suitable recycling pathways and promote the reuse of TCEs.